Owlet (OWLT) Liabilities and Shareholders Equity (2020 - 2026)
Owlet (OWLT) reported Liabilities and Shareholders Equity of $86.8 million for Q1 2026, up 68.8% year-over-year from $51.4 million in Q1 2025, and up 1.31% quarter-over-quarter from $85.6 million in Q4 2025.
Owlet (OWLT) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
Owlet (OWLT) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $86.8 million in Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $86.8 million, up 68.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $310.8 million (up 53.15% YoY), and the FY2025 annual result was $85.6 million, up 72.94% from the prior year.
- Liabilities and Shareholders Equity advanced to $86.8 million in Q1 2026 per OWLT's latest filing, from $85.6 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $124.1 million in Q1 2022 and troughed at $42.3 million in Q3 2023.
- A 5-year average of $66.6 million and a median of $58.1 million in 2022 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity plunged 58.51% in 2022, then soared 72.94% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $58.1 million in 2022, then declined by 24.06% to $44.1 million in 2023, then advanced by 12.22% to $49.5 million in 2024, then soared by 72.94% to $85.6 million in 2025, then advanced by 1.31% to $86.8 million in 2026.
- Business Quant data shows OWLT's Liabilities and Shareholders Equity at $86.8 million in Q1 2026, $85.6 million in Q4 2025, and $74.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Owlet | 136.53 Mn | 95.52 Mn | 12.24 Mn | 86.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86.76 Mn |
| Dec 31, 2025 | 85.63 Mn |
| Sep 30, 2025 | 74.87 Mn |
| Jun 30, 2025 | 63.54 Mn |
| Mar 31, 2025 | 51.40 Mn |
| Dec 31, 2024 | 49.52 Mn |
| Sep 30, 2024 | 56.13 Mn |
| Jun 30, 2024 | 45.90 Mn |
| Mar 31, 2024 | 43.83 Mn |
| Dec 31, 2023 | 44.12 Mn |
| Sep 30, 2023 | 42.29 Mn |
| Jun 30, 2023 | 57.26 Mn |
| Mar 31, 2023 | 65.93 Mn |
| Dec 31, 2022 | 58.10 Mn |
| Sep 30, 2022 | 80.68 Mn |
| Jun 30, 2022 | 101.88 Mn |
| Mar 31, 2022 | 124.12 Mn |
| Dec 31, 2021 | 140.05 Mn |
| Sep 30, 2021 | 160.28 Mn |
| Jun 30, 2021 | 230.80 Mn |